Skip to main content

Table 1 Demographic and clinical comparison between populations

From: Rate of aspiration pneumonia in hospitalized Parkinson’s disease patients: a cross-sectional study

 

Total (n = 339)

Aspiration pneumonia (n = 8)

Non-aspiration pneumonia (n = 331)

P

Age, y (SD)

74.1 (10.1)

76.6 (12.4)

74.1 (10.1)

0.62a

Male, no. (%)

206 (60.8 %)

4 (50)

202 (61)

0.72b

Charlson index, no. (SD)

5.9 (1.5)

5.9 (1.1)

5.9 (1.5)

0.90a

Disease duration, y (SD)

6.4 (6.3)

3.8 (2.2)

6.4 (6.3)

0.59a

Hoehn and Yahr stage IV-V, no. (%)

165 (48.7)

4 (50)

161 (48.6)

1.00b

LED, no. (SD)

502.4 (487.9)

716.6 (488.5)

496.8 (487.5)

0.15a

Neurologist consulted, no. (%)

83 (24.5)

1 (12.5)

82 (24.8)

0.71b

Length of hospital stay, days (SD)

6 (7.1)

4.3 (3.6)

6.0 (7.2)

0.56a

Swallow evaluations or aspiration precautions, no. (%)

158 (46.6)

7 (87.5)

1 (12.5)

0.03b

Days from admission to barium evaluation, no. (SD)

4.5 (4.3)

4.3 (4.3)

4.5 (4.4)

0.98a

Days from admission to clinical evaluation, no. (SD)

3.5 (4.7)

4.3 (2.2)

3.5 (4.8)

0.13a

  1. aMann–Whitney U Test
  2. bFisher’s Exact Test